Argent BioPharma Limited (ASX:RGT)
Australia · Delayed Price · Currency is AUD 0.0190
0.00 (0.00%)
Nov 9, 2026, 2:29 PM AEDT
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 2.24 million as of November 9, 2026. It is the 48,583rd most valuable company in the world and the 1,651st biggest in Australia. Its market cap has decreased by 62.11% in one year.
Market Cap
2.24M
Enterprise Value
11.69M
Revenue
161.19K
Global Rank
Country Rank
#1,651 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has decreased from 3.12M to 2.24M, a decrease of -28.17%. That is a compound annual growth rate of -2.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 2.24M | -61.64% |
| Dec 31, 2025 | 5.84M | -36.74% |
| Dec 31, 2024 | 9.23M | -46.77% |
| Dec 29, 2023 | 17.33M | -45.96% |
| Dec 30, 2022 | 32.07M | -67.88% |
| Dec 31, 2021 | 99.85M | 123.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syntara | 35.33M |
| Peak Processing | 18.75M |
| IDT Australia | 15.38M |
| Vitura Health | 13.25M |
| Cann Group | 8.30M |
| ECS Botanics Holdings | 8.01M |
| Epsilon Healthcare | 7.78M |
| Percheron Therapeutics | 5.95M |